NEW YORK STEM CELL FOUNDATION INC has a total of 14 patent applications. It decreased the IP activity by 50.0%. Its first patent ever was published in 2012. It filed its patents most often in Australia, United States and Singapore. Its main competitors in its focus markets biotechnology, pharmaceuticals and medical technology are NEW YORK STEM CELL FOUND INC, NEW YORK STEM CELL FOUNDATION and TAMPEREEN YLIOPISTO.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 10 | |
#2 | United States | 2 | |
#3 | Singapore | 1 | |
#4 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Medical technology | |
#4 | Measurement | |
#5 | Chemical engineering | |
#6 | Mechanical elements |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Analysing materials | |
#4 | Microbiology | |
#5 | Object sterilising | |
#6 | Therapeutic chemical compounds | |
#7 | Implantable devices | |
#8 | Venting or aerating devices | |
#9 | Dentistry | |
#10 | Chemical or physical laboratory devices |
# | Name | Total Patents |
---|---|---|
#1 | Noggle Scott | 6 |
#2 | Chang Stephen | 4 |
#3 | Maria De Peppo Giuseppe | 2 |
#4 | Ab Vensand Lauren | 2 |
#5 | Solomon Susan L | 2 |
#6 | De Peppo Giuseppe Maria | 2 |
#7 | Benvenisty Nissim | 2 |
#8 | Fossati Valentina | 2 |
#9 | Dusenberry Carmen | 2 |
#10 | Sproul Andrew | 2 |
Publication | Filing date | Title |
---|---|---|
AU2017240687A1 | Customized hybrid bone-implant grafts | |
US2016194593A1 | Perfusion bioreactor | |
AU2015263951A1 | Functional oligodendrocytes derived from pluripotent stem cells and methods of making and using the same | |
AU2014373966A1 | Tissue grafts and methods of making and using the same | |
WO2014201412A1 | Pluripotent stem cells derived from non-cryoprotected frozen tissue and methods for making and using the same |